The latest news:

• Positive Phase 2 Results from Agenus' Brain Cancer Vaccine Published in Neuro-Oncology         Pretty good news on a vaccine trial....  there was no control group but it beat historical controls. Survival (I assume after recurrence) was 11 months for the vaccine, compared to 3 to 9 months for historical controls.  
  



• Articles Added to the Clinical Trials and Noteworthy Treatments For Brain Tumors Website         We are in the process of updating and adding articles to the website. If you have any suggestions for topics or how to better organize them, let me know!  
  



• Two-drug combination slows malignant brain tumors in mice         Interesting combination -  blocking both PI3K and Shh..  They  do not say which drugs  are  involved or the name  of the  trial.  There was an oral  SHH inhibitor approved recently - Erivedge.  And there is alot  of excitement over the drug BKM120 which is still experimental. Will let you know when I find out which trial this is.
  



• Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical Study of BLZ-100 Tumor PaintTM technology enters clinical stage of development         This one is for skin cancer only, but the technology was invented to help surgeons see where brain tumors are - to tell the difference between normal and cacnerous.  We are trying to help raise the money needed to get a brain tumor trial going - hopefully pediatric brain tumor!  That is where it is needed most.
  



• IBTA Newsletter         From our friends at the IBTA.  This newsletter includes the highlights from the recent Society of Neuro-oncology meeting.  That article is a must read.
  

BrainTumor Co-Payment Assistance Program Status:

• OPEN to new applicants